EN
HI
Summary
As of 16 Oct, 2026, Marksans Pharma stock price is ₹307.85. During the trading session, the stock has moved between an intraday low of ₹306.55 and an intraday high of ₹315.10. Over the last 52 weeks, Marksans Pharma has traded between ₹155.00 and ₹350.95.
The stock has recorded a trading volume of 6,81,887 shares,. Its Average Traded Price (ATP) is ₹310.58, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 6 @ ₹307.85.
Marksans Pharma has an upper circuit limit of ₹376.95 and a lower circuit limit of ₹251.35. The total value traded stands at ₹21.18 CR, and the delivery percentage for the day is 45.19%.
The stock is currently traded with a market lot size of 1. Marksans Pharma also offers a dividend yield of 0.29%.
Marksans Pharma Share Price Chart
Marksans Pharma Share Key Metrics
Volume
6.82 L
Market Cap
13954.48 CR
LTQ@LTP
6@307.85
ATP
310.58
Var Margin
22.29 %
Circuit Range
251.35-376.95
Delivery %
45.19 %
Value
21.18 CR
ASM/GSM
No
Market Lot
1
Marksans Pharma Fundamentals
P/E Ratio
27.55
P/B Ratio
4.48
Div. Yield
0.29
Sector P/E
41.22
Sector P/B
3.45
Sec. Div. Yield
0.53
Marksans Pharma Resistance and Support
Pivot 315.8
Resistance
First Resistance
319.25
Second Resistance
324.35
Third Resistance
327.8
Support
First Support
310.7
Second Support
307.25
Third Support
302.15
Marksans Pharma Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Thu Oct 15 2026 | 314.2 | 307.85 | -2.00% | 315.1 | 306.55 |
| Wed Oct 14 2026 | 315 | 314.14 | -0.98% | 320.89 | 312.35 |
| Tue Oct 13 2026 | 316.95 | 317.25 | 0.27% | 318 | 309.79 |
Marksans Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-12 | Quarterly Results |
| 2026-05-26 | Audited Results & Final Dividend |
| 2026-02-05 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-05-19 | Audited Results & Final Dividend |
| 2025-02-11 | Quarterly Results |
| 2024-11-12 | Quarterly Results |
| 2024-08-13 | Quarterly Results |
Marksans Pharma Management
| Name | Position |
|---|---|
| Harshavardhan Panigrahi | Company Secretary & Compliance Officer |
| Mark Saldanha | Chairman & Managing Director |
Marksans Pharma Similar Stocks
Alembic Pharmaceuticals Ltd.
792.65
0.20 (0.03%)
Natco Pharma Ltd.
784.95
2.30 (0.29%)
Jubilant Pharmova Ltd.
938.20
-0.70 (0.07%)
Dr. Agarwal's Health Care Ltd.
477.15
9.25 (1.98%)
Vijaya Diagnostic Centre Ltd.
1387.40
-14.80 (1.06%)
Concord Biotech Ltd.
1353.30
-28.80 (2.08%)
Alivus Life Sciences Ltd.
1341.80
-6.20 (0.46%)
CORONA Remedies Ltd.
2044.80
-14.80 (0.72%)
Rainbow Children's Medicare Ltd.
1246.60
-0.10 (0.01%)
Akums Drugs & Pharmaceuticals Ltd.
749.80
-20.15 (2.62%)
Marksans Pharma FAQs
The Buying Price of Marksans Pharma share is 307.85 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Marksans Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Marksans Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Marksans Pharma shares is 27.55. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Marksans Pharma shares is 4.48. Useful to assess the stock's value relative to its book value.
To assess Marksans Pharma’s valuation compare Sector P/E, P/B which are 41.22 & 3.45 with sector averages, along with growth rates and financial metrics.
The Market Cap of Marksans Pharma is 13954.48 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Marksans Pharma share price is 350.95 & 155.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Marksans Pharma belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in MARKSANS
